• Product NameSuplatast tosilate
• Brief DescriptionInhibitors
• Purification99.00%
• Biological ActivitySuplatast Tosilate is a novel capsular anti-asthmatic agent that suppresses both IgE production, IL-4 and IL-5 synthesis with IC50 above 100 μM.
• Target NameIL Receptor inhibitor
• CAS No. 94055-76-2
• Calculated MW 499.64
• Formulation C23H33NO7S2
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Nervous system
  SMILES:CCOCC(O)COC1=CC=C(NC(=O)CC[S+](C)C)C=C1
  Pathways:Immunology/Inflammation
  Receptor:Th2 cytokine
  Boling pt:
  Melting pt:84-87C
  Solubility:Ethanol: 100 mg/mL (200.14 mM); Water: 100 mg/mL (200.14 mM); DMSO: 100 mg/mL (200.14 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Mimura T, et al. J Pharmacol Exp Ther, 2005, 314(1), 293-301.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting